Falsely low parathyroid hormone secondary to biotin interference: A case series

Endocrine Practice

Volumn 19, Issue 3, 2013, Pages 451-455

  Waghray, Abhijeet ^a   Milas, Mira ^a   Nyalakonda, Kavita ^a   Siperstein, Allan E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; CALCIUM; PARATHYROID HORMONE;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HORMONE DETERMINATION; HUMAN; HYPERPARATHYROIDISM; NEUROPATHIC PAIN; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; SIDE EFFECT; SURGICAL PATIENT; VITAMIN SUPPLEMENTATION;

EID: 84880107096     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP12158.OR     Document Type: Article

References (16)

1. Endres DB, Rude RK. Mineral and bone metabolism. In: Burtis CA, Ashwood ER, Bruns DE, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th ed. St. Louis, MO: Elsevier Saunders, 2006: 1891-1965.
2. Siperstein A, Milas M. Comprehensive parathyroidectomy fo. The treatment of PHPT. In: Fischer JE, Jones DB, Pomposelli FB, Upchurch GR. Fischer's Mastery of Surgery. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2011: 486-492.
3. Boudourakis L, Sosa JA. Outcomes analysis in parathyroid surgery. In: Fischer JE, Jones DB, Pomposelli FB, Upchurch GR. Fischer's Mastery of Surgery. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2011. 339.
4. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med. 2000;343:1863-1875.
5. Chapman-Smith A, Cronan JE Jr. Molecular biology of biotin attachment to proteins. J Nutr. 1999;129(2S Suppl):477S-484S.
6. Roche Cobas E411® parathyroid hormone assay package insert. English.
7. Siemens Advia Centaur® parathyroid hormone assay package insert. English. 8. DeGroot LJ, Jameson JL, eds. Endocrinology. 4th ed. Philadelphia, PA: WB Saunders; 2001.
8. Bilezikian JP, Khan AA, Potts JT Jr. Guidelines fo. The management of asymptomatic primary hyperparathyroidism: summary statement fro. The third international workshop. J Clin Endocrinol Metab. 2009;94:335-339.
9. Zempleni J, Kuroishi T. Biotin. Adv Nutr. 2012;3:213-214.
10. Mock DM. Biotin. In: Coates PM, Betz JM, Blackman MR, et al. Encyclopedia of Dietary Supplements. 2nd ed. New York, NY: Marcel Dekker; 2005: 31-39.
11. Souberbielle JC, Boutten A, Carlier MC, et al. Inter-method variability in PTH measurement: implication fo. The care of CKD patients. Kidney Int. 2006;70:345-350.
12. Kirschmann J. Nutrients. In: Kirschmann GJ, Kirschmann JD, eds. Nutrition Almanac. New York, NY: McGraw-Hill; 1996: 37-38.
13. Combs GF. Biotin. In: Combs, GF. The Vitamins: Fundamental Aspects in Nutrition and Health. San Diego, CA: Elsevier, Inc.; 2008: 331-344.
14. Grebe SKG. Diagnosis and management of thyroid carcinoma: a focus on serum thyroglobulin. Expert Rev Endocrinol Metab. 2009;4:25-43.
15. Bitsch R, Salz I, Hötzel D. Studies on bioavailability of oral biotin doses for humans. Int J Vitam Nutr Res. 1989; 59:65-71.
16. Wang KS, Kearns GL, Mock DM. The clearance and metabolism of biotin administered intravenously to pigs in tracer and physiologic amounts is much more rapid than previously appreciated. J Nutr. 2001;131:1271-1278.